Bruce N. Kuhlik
2012
Compensation breakdown
Change in Pension Value and Nonqualified Deferred Compensation Earnings | $732,748 |
---|---|
Non-Equity Incentive Plan | $898,270 |
Option Awards | $919,999 |
Salary | $791,664 |
Stock Awards | $1,236,796 |
Other | $21,250 |
Total | $4,600,727 |
Kuhlik received $1.2M in stock awards, accounting for 27% of the total pay in 2012.
Kuhlik also received $732.7K of change in pension value and nonqualified deferred compensation earnings, $898.3K in non-equity incentive plan, $920K in option awards, $791.7K in salary and $21.3K in other compensation.
Rankings
In 2012, Bruce N. Kuhlik's compensation ranked 1,379th out of 11,487 executives tracked by ExecPay. In other words, Kuhlik earned more than 88.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,379 out of 11,487 | 88th |
Division Manufacturing | 499 out of 4,253 | 88th |
Major group Chemicals And Allied Products | 110 out of 1,198 | 91st |
Industry group Drugs | 61 out of 920 | 93rd |
Industry Pharmaceutical Preparations | 53 out of 700 | 92nd |
Kuhlik's colleagues
We found five more compensation records of executives who worked with Bruce N. Kuhlik at Merck & Co. in 2012.
2012
Kenneth Frazier
Merck & Co.
Chief Executive Officer
2012
Adam Schechter
Merck & Co.
Executive Vice President and President, Global Human Health
2012
Peter Kim
Merck & Co.
Executive Vice President and President, Merck Research Laboratories
2012
Peter Kellogg
Merck & Co.
Chief Financial Officer
2012
Richard Bowles
Merck & Co.